Products

What will AGI do for Betaxolol or levobetaxolol?

This classification denotes a beta-adrenergic blocking agent with the molecular formula C18H29NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O0ZR1R6RZ2, chemically known as 2-propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)- but generally known as betaxolol, which bears US NIH Compound Identifier 2369. Betaxolol most often comes in base and hydrochloride forms. European Medicines Agency schedules Betaxolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05804MIG. The term BETAXOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules betaxolol in its Anatomical Therapeutic Chemical (ATC) Classification. BETAXOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Betaxolol or levobetaxolol bears US NLM identifiers UMLS ID C0005320 and NCI Concept Code C61652. SMILES: O(CC1CC1)CCC1CCC(OCC(O)CNC(C)C)CC1.